Locally Advanced Rectal Cancer
Showing 26 - 50 of 57
Tislelizumab, Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment Trial in Changchun (Tilelimumab)
Not yet recruiting
- Tislelizumab
- +3 more
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
May 26, 2021
Locally Advanced Rectal Cancer Trial in Seoul (Arm A : standard neoadjuvant chemoradiotherapy group, Arm B : adjuvant FOLFOX
Active, not recruiting
- Locally Advanced Rectal Cancer
- Arm A : standard neoadjuvant chemoradiotherapy group
- Arm B : adjuvant FOLFOX group
-
Seoul, Korea, Republic ofSeverance Hospital
Apr 21, 2021
Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response Trial in Roma (RT Dose escalation
Recruiting
- Neoadjuvant Chemoradiotherapy
- +2 more
- RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Mar 22, 2021
Locally Advanced Rectal Cancer Trial in Hangzhou (mFOLFOXIRI, Chemoradiotherapy)
Recruiting
- Locally Advanced Rectal Cancer
- mFOLFOXIRI
- Chemoradiotherapy
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Mar 21, 2021
Locally Advanced Rectal Cancer Trial in Germany (Trifluridine/tipiracil chemoradiation, Capecitabine based chemoradiation)
Recruiting
- Locally Advanced Rectal Cancer
- Trifluridine/tipiracil chemoradiation
- Capecitabine based chemoradiation
-
Flensburg, Schleswig-Holstein, Germany
- +7 more
Mar 18, 2021
Locally Advanced Rectal Cancer Trial in Seoul (Neoadjuvant CCRT+operation +/- adjuvant treatment)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Neoadjuvant CCRT+operation +/- adjuvant treatment
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Feb 1, 2021
Locally Advanced Rectal Cancer Trial in Beijing (FOLFOXIRI)
Completed
- Locally Advanced Rectal Cancer
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021
Locally Advanced Rectal Cancer Trial in Hangzhou (PD-1 antibody, Capecitabine, Oxaliplatin)
Not yet recruiting
- Locally Advanced Rectal Cancer
- PD-1 antibody
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 4, 2020
Locally Advanced Rectal Cancer Trial in Dublin (IMRT)
Terminated
- Locally Advanced Rectal Cancer
- IMRT
-
Dublin, Ireland
- +2 more
Jul 30, 2020
Locally Advanced Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Irinotecan)
Not yet recruiting
- Locally Advanced Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaZhen Zhang
Jun 1, 2020
Locally Advanced Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Irinotecan)
Not yet recruiting
- Locally Advanced Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaZhen Zhang
Jun 1, 2020
Locally Advanced Rectal Cancer Trial in Shanghai (drug, radiation, other)
Recruiting
- Locally Advanced Rectal Cancer
- Dendrobium Huoshanense Granules
- +4 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 16, 2020
Locally Advanced Rectal Cancer Trial in Oxford (biological, drug, radiation)
Recruiting
- Locally Advanced Rectal Cancer
- Enadenotucirev
- +2 more
-
Oxford, United KingdomThe Churchill Hospital, Oxford University Hospitals Trust
Mar 3, 2020
Locally Advanced Rectal Cancer Trial in Hangzhou (mFOLFOXIRI)
Unknown status
- Locally Advanced Rectal Cancer
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Nov 18, 2019
Locally Advanced Rectal Cancer Trial in Seoul (Hyperthermia with concurrent chemo-radiation therapy)
Terminated
- Locally Advanced Rectal Cancer
- Hyperthermia with concurrent chemo-radiation therapy
-
Seoul, Korea, Republic ofSamsung Medical Center
Oct 13, 2019
Locally Advanced Rectal Cancer Trial in Belgium (Oxaliplatin, Bevacizumab, Capecitabine)
Locally Advanced Rectal Cancer Trial in Spain (3DCRT treatment (sequential boost), Dose Escalation Intensity Modulated
Unknown status
- Locally Advanced Rectal Cancer
- 3DCRT treatment (sequential boost)
- Dose Escalation Intensity Modulated Radiotherapy treatment
-
Elche, Alicante, Spain
- +8 more
Jun 24, 2019
Locally Advanced Rectal Cancer Trial in Seoul (preoperative short-course radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- preoperative short-course radiotherapy
-
Seoul, Korea, Republic ofThe Division of Colon and Rectal Surgery, Department of Surgery,
Feb 12, 2019
Locally Advanced Rectal Cancer Trial in Shanghai (Blood concentration check)
Unknown status
- Locally Advanced Rectal Cancer
- Blood concentration check
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 30, 2019
Locally Advanced Rectal Cancer, Electrochemotherapy, Neoadjuvant Therapy Trial in Herlev, Roskilde (Electrochemo with bleomycin,
Unknown status
- Locally Advanced Rectal Cancer
- +3 more
- Electrochemotherapy with bleomycin
- EndoVE
-
Herlev, Capitol Region, Denmark
- +1 more
Jan 24, 2019
Locally Advanced Rectal Cancer Trial in Shanghai (Radiation, Capecitabine, Irinotecan)
Unknown status
- Locally Advanced Rectal Cancer
- Radiation
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 19, 2019
Locally Advanced Rectal Cancer Trial in Gottingen (Translational Research and multimodal treatment)
Unknown status
- Locally Advanced Rectal Cancer
- Translational Research and multimodal treatment
-
Gottingen, Lower Saxony, GermanyUniversity Medical Center Goettingen
Oct 15, 2018
LOCALLY ADVANCED RECTAL CANCER Trial in Elche (Organ Preservation)
Recruiting
- LOCALLY ADVANCED RECTAL CANCER
- Organ Preservation
-
Elche, Alicante, SpainHospital General Universitario de Elche
Sep 25, 2018
Rectal Cancer, Locally Advanced Rectal Cancer, Hyperthermia Trial in Tübingen (other, radiation, drug)
Completed
- Rectal Cancer
- +5 more
- Deep regional hyperthermia
- +2 more
-
Tübingen, Baden-Württemberg, GermanyUniversity Hospital Tübingen, Department of Radiation Oncology
Feb 12, 2018